DANA-FARBER CANCER INSTITUTE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 34947
 
  
 
C07K PEPTIDES 18221
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 16221
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 15767
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13950
 
  
 
C07D HETEROCYCLIC COMPOUNDS 9177
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 5150
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3168
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2372
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2228

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0074,062 COMPOSITIONS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCERApr 24, 17Mar 15, 18[G01N]
2018/0067,117 Biomarkers for the early detection of breast cancerNov 21, 17Mar 08, 18[C12Q, G01N]
2018/0055,922 COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENSNov 01, 17Mar 01, 18[A61K, C12Q, G01N]
2018/0044,376 Method for Preparing Largazole Analogs and Uses ThereofMar 03, 16Feb 15, 18[A61K, C07B, C07K]
2018/0036,441 ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)Jul 31, 17Feb 08, 18[A61K]
2018/0030,147 CARBONIC ANHYDRASE IX SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOFDec 21, 15Feb 01, 18[A61K, C12N, C07K]
2017/0369,855 SYSTEMS AND METHODS FOR GENOME MODIFICATION AND REGULATIONDec 24, 15Dec 28, 17[C12Q, C12N]
2017/0360,801 BROMODOMAIN INHIBITOR AS ADJUVANT IN CANCER IMMUNOTHERAPYDec 04, 15Dec 21, 17[A61K, C12N]
2017/0362,297 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOFDec 21, 15Dec 21, 17[C07K]
2017/0348,391 MULTIPLE-VARIABLE IL-2 DOSE REGIMEN FOR TREATING IMMUNE DISORDERSOct 07, 15Dec 07, 17[A61K, G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9908872 Methods to treat lymphoplasmacytic lymphomaDec 12, 14Mar 06, 18[A61K, C07D]
9908884 EGFR inhibitors and methods of treating disordersMay 05, 10Mar 06, 18[C07D]
9902759 BH3 peptides and methods of use thereofMar 17, 16Feb 27, 18[C07K]
9897597 High-throughput structure determination using nucleic acid calipersApr 23, 15Feb 20, 18[C12Q, G01N]
9890127 Compounds and compositions for the treatment of cancerMar 11, 14Feb 13, 18[A61K, C07D]
9890429 Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancerFeb 28, 13Feb 13, 18[A61K, C12Q, G01N, G06F]
9884089 BPI and its congeners as radiation mitigators and radiation protectorsJun 01, 16Feb 06, 18[A61K, C07K]
9884913 Antibody molecules to TIM-3 and uses thereofMar 17, 17Feb 06, 18[A61K, G01N, C07K]
9879003 Host targeted inhibitors of dengue virus and other virusesMar 15, 13Jan 30, 18[C07D]
9880169 MEK1 mutation conferring resistance to RAF and MEK inhibitorsJan 29, 16Jan 30, 18[C12Q, C12N, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0224,700 USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORSAbandonedAug 08, 15Aug 10, 17[A61K]
2017/0160,267 METHODS OF DETERMINING CELLULAR CHEMOSENSITIVITYAbandonedMar 17, 16Jun 08, 17[G01N]
2017/0073,687 MELK Regulation for the Treatment of Breast CancerAbandonedNov 29, 16Mar 16, 17[C12N]
2016/0362,478 CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIESAbandonedFeb 10, 15Dec 15, 16[A61K, C07K]
2016/0228,543 Continuous Cell Programming DevicesAbandonedApr 21, 16Aug 11, 16[A61K]
2016/0220,668 Continuous Cell Programming DevicesAbandonedApr 21, 16Aug 04, 16[A61K]
2016/0152,667 COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONSAbandonedFeb 09, 16Jun 02, 16[A61K, C07K]
2016/0122,829 Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 IsoformsAbandonedJun 02, 14May 05, 16[C12Q, C12N, G01N]
2016/0082,108 WIREFRAME NANOSTRUCTURESAbandonedSep 30, 15Mar 24, 16[A61K]
2015/0354,006 MARKERS FOR ACUTE LYMPHOBLASTIC LEUKEMIAAbandonedOct 15, 13Dec 10, 15[C12Q, G01N]
2015/0346,204 MEK Mutations Conferring Resistance to MEK InhibitorsAbandonedJun 10, 15Dec 03, 15[G01N]
2015/0322,528 BIOMARKERS ASSOCIATED WITH CDK INHIBITORSAbandonedJun 26, 13Nov 12, 15[A61K, C12Q, G01N]
2015/0292,033 METHOD OF DETERMINING CANCER PROGNOSISAbandonedApr 09, 15Oct 15, 15[C12Q]
2015/0283,227 SYNTHETIC ENV PROTEINSAbandonedOct 28, 13Oct 08, 15[A61K, C12N, C07K]
2015/0239,972 METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORSAbandonedMar 06, 15Aug 27, 15[G01N, C07K]
2015/0197,497 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOFAbandonedJun 25, 12Jul 16, 15[C07D]
2015/0110,717 METHODS OF INCREASING THE NUMBER OF TARGET CELLS RECOVERED FROM A FLUID SAMPLEAbandonedSep 07, 12Apr 23, 15[C12N, A01K, G01N]
2015/0087,598 TREATING MUC1-EXPRESSING CANCERS WITH HELICASE INHIBITORSAbandonedMay 13, 13Mar 26, 15[A61K]
2015/0031,756 LENTIVIRAL VECTORS AND USES THEREOFAbandonedAug 01, 14Jan 29, 15[C12N, G01N]
2014/0378,469 LKB1/STK11 DELETION IN MELANOMA AND RELATED METHODSAbandonedFeb 06, 13Dec 25, 14[C12Q, G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.